General Information of the Compound
| Compound ID |
CP0568368
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(E)-N-[3-cyano-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H27N9O2
|
||||||||||||||||||
| Molecular Weight |
545.607
|
||||||||||||||||||
| Canonical SMILES |
CN1CCC[C@@H]1\C=C\C(=O)Nc1ccc2ncc(C#N)c(Nc3ccc(Oc4cc5nncn5cn4)c(C)c3)c2c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H27N9O2/c1-19-12-21(6-9-26(19)41-29-14-27-37-34-18-39(27)17-33-29)36-30-20(15-31)16-32-25-8-5-22(13-24(25)30)35-28(40)10-7-23-4-3-11-38(23)2/h5-10,12-14,16-18,23H,3-4,11H2,1-2H3,(H,32,36)(H,35,40)/b10-7+/t23-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
ZOLXNVOLRGVYNI-BWAMLYQTSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00922, Epidermal growth factor receptor
Protein ID: PT01233, Receptor tyrosine-protein kinase erbB-2